{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:40:07Z","timestamp":1756359607292,"version":"3.44.0"},"reference-count":12,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,1,31]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:p>A patient with Dupuytren\u2019s disease noted progressive disappearance of the contractures of both hands over a 3-year period while taking coenzyme Q10 daily for an unrelated condition. The function and appearance of his hands were restored to almost normal.<\/jats:p>","DOI":"10.1136\/bcr-2018-226419","type":"journal-article","created":{"date-parts":[[2019,3,2]],"date-time":"2019-03-02T05:35:11Z","timestamp":1551504911000},"page":"e226419","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Could coenzyme Q10 be the treatment for Dupuytren\u2019s disease?"],"prefix":"10.1136","volume":"12","author":[{"given":"Wilma","family":"Lourens","sequence":"first","affiliation":[{"name":"Department of Medicine, Sligo University Hospital, Sligo, Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"2025082722144446000_12.3.e226419.1","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1302\/0301-620X.100B9.BJJ-2017-1194.R2","article-title":"Treatment of dupuytren\u2019s contracture","volume":"100-B","author":"Soreide","year":"2018","journal-title":"Bone Joint J"},{"key":"2025082722144446000_12.3.e226419.2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2106\/00004623-195941040-00008","article-title":"Dupuytren\u2019s contracture; a new concept of the pathogenesis correlated with surgical management","volume":"41-A","author":"LUCK","year":"1959","journal-title":"J Bone Joint Surg Am"},{"key":"2025082722144446000_12.3.e226419.3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.hcl.2018.03.005","article-title":"Alternative and adjunctive treatments for dupuytren disease","volume":"34","author":"Werker","year":"2018","journal-title":"Hand Clin"},{"key":"2025082722144446000_12.3.e226419.4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1301100110"},{"key":"2025082722144446000_12.3.e226419.5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ebiom.2018.06.022","article-title":"Anti-tumour necrosis factor therapy for dupuytren\u2019s disease: a randomised dose response proof of concept phase 2a clinical trial","volume":"33","author":"Nanchahal","year":"2018","journal-title":"EBioMedicine"},{"key":"2025082722144446000_12.3.e226419.6","doi-asserted-by":"publisher","DOI":"10.1038\/ijir.2010.20"},{"key":"2025082722144446000_12.3.e226419.7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/4653512","article-title":"Recent pathophysiological aspects of peyronie\u2019s disease: role of free radicals, rationale, and therapeutic implications for antioxidant treatment-literature review","volume":"2017","author":"Paulis","year":"2017","journal-title":"Adv Urol"},{"key":"2025082722144446000_12.3.e226419.8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11930-015-0045-y","article-title":"Peyronie\u2019s disease: a review of etiology, diagnosis, and management","volume":"7","author":"Bilgutay","year":"2015","journal-title":"Curr Sex Health Rep"},{"key":"2025082722144446000_12.3.e226419.9","first-page":"129","article-title":"Rationale of combination therapy with antioxidants in medical management of Peyronie\u2019s disease: results of clinical application","volume":"9","author":"Paulis","year":"2017","journal-title":"Res Rep Urol"},{"key":"2025082722144446000_12.3.e226419.10","doi-asserted-by":"crossref","unstructured":"Zhai J , Bo Y , Lu Y , et al . Effects of co-enzyme q10 on markers of inflammation: a systematic review and meta-analysis. PloS one 2017;12.","DOI":"10.1371\/journal.pone.0170172"},{"key":"2025082722144446000_12.3.e226419.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016841","article-title":"Can coenzyme Q10 supplementation effectively reduce human tumour necrosis factor-\u03b1 and interleukin-6 levels in chronic diseases? Protocol for a systematic review and meta-analysis of randomised controlled trials","volume":"7","author":"Farsi","year":"2017","journal-title":"BMJ Open"},{"key":"2025082722144446000_12.3.e226419.12","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00044"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-226419","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T05:14:57Z","timestamp":1756358097000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-226419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,1]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bcr-2018-226419"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-226419","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}